%0 Case Reports
%T Complete Response With Immunotherapy: A Case of Metastatic Bladder Cancer.
%A Singh B
%A Kaur P
%A Gupta S
%A Guragai N
%A Maroules M
%J J Investig Med High Impact Case Rep
%V 9
%N 0
%D Jan-Dec 2021
%M 34308703
暂无%R 10.1177/23247096211035603
%X Bladder cancer is the most common urinary tract malignancy. Platinum-based chemotherapy is the first line of treatment in locally advanced or metastatic bladder cancer. Immunotherapy has become a novel therapy option in a broad variety of malignancies including bladder cancer. Immunotherapy is approved as first line of treatment in patients who are ineligible for platinum-based chemotherapy and second-line treatment for metastatic urothelial cancer who progressed after platinum-based treatments. We present the case of an 83-year-old female with metastatic bladder cancer who was chemotherapy ineligible and had complete response with immune checkpoint inhibitor pembrolizumab.